4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting (track and trace); Drug importation; 340B Program; Authorized generics; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Patient Protection and Affordable Care Act; drug shortages.

LobbyistCovered position, as disclosed
MICHAEL BEER New LA, Rep. Dave Hobson
JENNY DIJAMES New LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN New —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare payment for diabetes testing strips. Drug rebates for Medicare Part D. Independent Payment Advisory Board (IPAB). House and Senate action on H.J. Res. 59 and possible drug industry issues.

LobbyistCovered position, as disclosed
KARINA LYNCH —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 59 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.